Amanote Research
Register
Sign In
Review: Rivastigmine May Improve Cognitive Outcomes in Alzheimer's Disease
Evidence-Based Mental Health
- United Kingdom
doi 10.1136/ebmh.3.1.10
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Date
February 1, 2000
Authors
R. Bullock
Publisher
BMJ
Related search
Adjunctive Rifampicin May Improve Outcomes in Staphylococcus Aureus Bacteraemia: A Systematic Review
Journal of Medical Microbiology
Medicine
Microbiology
Cognitive Debt and Alzheimer's Disease
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Does Treating Hearing Loss in Older Adults Improve Cognitive Outcomes? A Review
Journal of Clinical Medicine
Mild Cognitive Impairment in Parkinson's Disease Versus Alzheimer's Disease
Parkinsonism and Related Disorders
Gerontology
Geriatrics
Neurology
Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD
American Journal of Psychiatry
Psychiatry
Mental Health
Cognitive Impairment: Dementia and Alzheimer's Disease
Annual Review of Public Health
Medicine
Environmental
Public Health
Occupational Health
Alzheimer's Disease, Delusions and Cognitive Decline
Acta Neuropsychiatrica
Psychiatry
Mental Health
Biological Psychiatry
Sparse Bayesian Multi-Task Learning for Predicting Cognitive Outcomes From Neuroimaging Measures in Alzheimer's Disease
Review: Oestrogen Therapy After Menopause May Improve Cognitive Performance and May Reduce the Risk of Developing Dementia
Evidence-Based Mental Health
Psychiatry
Mental Health